Selective Tyrosine Kinase 2 Inhibition for Treatment of IBD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Inflammatory Bowel Diseases
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Selective Tyrosine Kinase 2 Inhibition for Treatment of Inflammatory Bowel Disease: New Hope on the Rise
Inflamm. Bowel Dis. 2021 Nov 15;27(12)2023-2030, S Danese, L Peyrin-BirouletFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.